Investor mix
4 investors on record; lead investors include Thuja Capital, Index Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Accelerator & incubator | 1 | 25% |
Specialty company developing a new therapeutic antibody for the prevention of heart failure after acute myocardial infarction
4 investors on record; lead investors include Thuja Capital, Index Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Accelerator & incubator | 1 | 25% |